Another failed attempt of neuroprotection: Progesterone for moderate and severe traumatic brain injury

Minerva Anestesiologica

Volumn 82, Issue 4, 2016, Pages 486-491

  Meyfroidt, Geert ^a   Taccone, Fabio S ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Brain injuries; Neuroprotection; Progesterone; Treatment outcome

Indexed keywords

PLACEBO; PROGESTERONE;

ARTICLE; CLINICAL ASSESSMENT; DISEASE SEVERITY; DRUG TREATMENT FAILURE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HEALTH CARE COST; HUMAN; MODERATE TRAUMATIC BRAIN INJURY; MORTALITY; MULTICENTER STUDY (TOPIC); NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SEVERE TRAUMATIC BRAIN INJURY; TRAUMATIC BRAIN INJURY;

EID: 84969228239     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hydera AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: Aglobal perspective. NeuroRehabilitation 2007;22:341-53.
2. Brain Trauma Foundation, American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), AANS/CNSJoint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring. J Neurotrauma 2007;24(Suppl 1):S37-S44.
3. Stein SC, Georgoff P, Meghan S, Mizra K, Sonnad SS. 150 years of treating severe traumatic brain injury: a systematic review of progress in mortality. J Neurotrauma 2010;27:1343-53.
4. Stocchetti N, Taccone FS, Citerio G, Pepe PE, Le Roux PD, Oddo M, Polderman KH, et al. Neuroprotection in acute brain injury: an up-to-date review. Crit Care 2015;19:186.
5. Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 2010;31:596-604.
6. Schumacher M, Robel P, Baulieu EE. Development and regeneration of the nervous system: a role for neurosteroids. Dev Neurosci 1996;18:6-21.
7. Attella MJ, Nattinville A, Stein DG. Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav Neural Biol 1987;48:352-67.
8. Wei J, Xiao G. The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects. Acta Pharmacologica Sinica 2013;34:1485-90.
9. Deutsch ER, Espinoza TR, Atif F, Woodall E, Kaylor J, Wright DW. Progesterones role in neuroprotection, a review of the evidence. Brain Res 2013;1530:82-105.
10. Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Amerg Med 2007;49:391-402.
11. Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 2008;12:R61.
12. Wright DW, Yeatts SD, Silbergleit R, Palesh YY, Hertzberg VS, Frankel M, et al. Very early administration of progesterone for acute traumatic brain injury. NEngl J Med 2014; 371:2457-66.
13. Skolnick BE, Maas AI, Narayan RK, Gerritsen van der Hoop R, MacAllister T, Ward JD, et al. Aclinical trial of progesterone for severe traumatic brain injury. NEngl J Med 2014;371:2467-76.
14. Shakeri M, Boustani MR, Pak N, Panahi F, Salehpour F, Lotfinia I, et al. Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma. Clin Neurol Neurosurg 2013;115:2019-22.
15. Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D, et al. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA2012;308:1641-50.
16. Tosetti P, Hicks RR, Theriault E, Phillips A, Koroshetz W, Draghia-Akli R. Toward an international initiative for traumatic brain injury research. J Neurotrauma 2013;30:1211-22.
17. Santarsieri M, Niyonkuru C, McCullough EH, Dobos JA, Dixon CE, Berga SL, et al. Cerebrospinal Fluid Cortisol and Progesterone Profiles and Outcomes Prognostication after Severe Traumatic Brain Injury. J Neurotrauma 2014;31:699-712.
18. Schumacher M, Mattern C, Ghoumari A, Oudinet JP, Liere P, Labombarda F, et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol 2014;113:6-39.
19. Cooke PS, Nanjappa MK, Yang Z, Wang KK. Therapeutic effects of progesterone and its metabolites in traumatic brain injury may involve non-classical signaling mechanisms. Front Neurosci 2013;7:108.
20. Uysal N, Baykara B, Kiray M, Cetin F, Aksu I, Dayi A, et al. Combined treatment with progesterone and magnesium sulfate positively affects traumatic brain injury in immature rats. Turk Neurosurg 2013;23:129-37.
21. Aminmansour B, Nikbakht H, Ghorbani A, Rezvani M, Rahmani P, Torkashvand M, et al. Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: Arandomized clinical trial with placebo group. Adv Biomed Res 2012;1:58.
22. Ioannidis JP. Why most published research findings are false. PLoSMed 2005;2:e124-e124.